Skip to main content
. 2019 Dec 16;98(50):e17814. doi: 10.1097/MD.0000000000017814

Figure 1.

Figure 1

The expression of serum miR-135a in NSCLC patients and healthy controls. Serum miR-135a was weakly expressed in NSCLC patients (mean ± SD: 0.40 ± 0.29) compared with healthy individuals (1.00 ± 0.40). The differences in serum miR-135a levels between NSCLC and healthy controls were significant, according to the Student t test. ∗∗∗P < .001. NSCLC = non-small cell lung cancer, SD = standard deviation.